D. E. Shaw & Co., Inc. Sesen Bio, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $126,348 - $221,542	-173,080 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$0.77 - $4.91 $119,271 - $760,549	-154,898 Reduced 47.23%	173,080 $137,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.66 $714,992 - $1.53 Million	327,978 New	327,978 $1.52 Million
Q3 2019 Nov 14, 2019	SELL	$1.04 - $1.51 $22,048 - $32,012	-21,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.95 - $2.46 $20,140 - $52,152	21,200 New	21,200 $32,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.